We provide consultancy services that translate complex biological and clinical data into clear, actionable decisions. DoseQuant offers scientific advice and quantitative modeling including pharmacometric analyses, clinical trial design, and review of technical and regulatory documents to support research and clinical programs, reducing uncertainty and enabling safer, more effective therapies.
Our Capabilities
Model-Informed Dose Optimization
Data-driven dose selection and optimization grounded in PK/PD principles
Quantitative Analytics
Robust modeling and simulation to support critical decisions
Research & Clinical
Support
Pharmacometric advice, clinical trial design, and expert review of protocols, analysis plans, and regulatory documents
What DoseQuant Does
DoseQuant translates complex pharmacology data into clear, decision-focused insights. By integrating pre-clinical and clinical data with pharmacometric modeling and simulation, DoseQuant supports dose selection, dose optimization, and interpretation across drug development and clinical research programs. DoseQuant also provides expert input into clinical trial design, protocol development, and critical review of study and regulatory documents.
Who is it for?
DoseQuant works with teams who rely on quantitative evidence to guide high-stakes decisions, including:
- Pharmaceutical and biotechnology companies
- Clinical researchers and trial teams
- Quantitative scientists and pharmacometricians
- Biotechnology Investors
Why DoseQuant?
Science-first approach
Decisions grounded in quantitative pharmacology
Transparent workflow
Clear assumptions, methods, and interpretations
Decision-driven outputs
Analyses designed to inform real-world decisions, not just generate results
Credibility
Methods and conclusions that stand up to regulatory and scientific scrutiny
About DoseQuant
DoseQuant was founded to bridge rigorous quantitative science with practical decision-making, helping teams move from data to action with confidence.
DoseQuant is led by Dr. Joel Tarning, Professor of Clinical Pharmacology at the University of Oxford and an internationally recognized expert in pharmacometrics and dose optimization. He has over 20 years of experience applying quantitative modeling to support drug development and clinical decision-making, with a particular focus on anti-infective therapies and underserved populations, including young children and pregnant women. His work has directly informed international treatment guidelines, including multiple World Health Organization (WHO) recommendations, and he has
published more than 270 peer-reviewed scientific articles in international journals. Through DoseQuant, he brings rigorous, transparent quantitative science into practical decision support for research and clinical programs.
Precision. Insight. Impact.
Interested in discussing a project or collaboration?
Get in touch to explore how DoseQuant can support your work.
Get In Touch